Cancer Res (2023) 83 (8_Supplement): LB215.
Mol Cancer Ther (2021) 20 (12_Supplement): P207.
You do not currently have access to this content.
KRAS pathways are frequently upregulated in cancers bearing KRAS mutations or by other signaling modifications. Also, resistance to KRAS G12C inhibitors and other KRAS/RAF/MEK pathway drugs is ...
Zentalis Pharmaceuticals, San Diego, CA.
Introduction: EBV-associated nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer that is prevalence in southern China and Southeast Asia. While radiotherapy or concurrent ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Cancer Res (2026) 86 (5_Supplement_2): A010.
Expression of the epithelial cytokine, thymic stromal lymphopoietin (TSLP), has been observed across several barrier surfaces and plays a critical role in both physiological and pathological processes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results